Created at	Source	Raw Value	Validated value
June 25, 2024, noon	usa	1. mild covid-19 disease (minor clinical symptoms, imaging does not show signs of lung inflammation) 2. recent history of or any in-hospital exposure to investigational medications targeting covid-19 3. alt/ast \> 5 times the upper limit of normal. 4. known hypersensitivity to ramelteon 5. pregnancy 6. severe hepatic insufficiency 7. fluvoxamine use	1. mild covid-19 disease (minor clinical symptoms, imaging does not show signs of lung inflammation) 2. recent history of or any in-hospital exposure to investigational medications targeting covid-19 3. alt/ast \> 5 times the upper limit of normal. 4. known hypersensitivity to ramelteon 5. pregnancy 6. severe hepatic insufficiency 7. fluvoxamine use
Nov. 16, 2021, 6:30 p.m.	usa	mild covid-19 disease (minor clinical symptoms, imaging does not show signs of lung inflammation) recent history of or any in-hospital exposure to investigational medications targeting covid-19 alt/ast > 5 times the upper limit of normal. known hypersensitivity to ramelteon pregnancy severe hepatic insufficiency fluvoxamine use	mild covid-19 disease (minor clinical symptoms, imaging does not show signs of lung inflammation) recent history of or any in-hospital exposure to investigational medications targeting covid-19 alt/ast > 5 times the upper limit of normal. known hypersensitivity to ramelteon pregnancy severe hepatic insufficiency fluvoxamine use
Oct. 26, 2020, 11:31 p.m.	usa	1. mild covid-19 disease (minor clinical symptoms, imaging does not show signs of lung inflammation) 2. recent history of or any in-hospital exposure to investigational medications targeting covid-19 3. alt/ast > 5 times the upper limit of normal. 4. known hypersensitivity to ramelteon 5. pregnancy 6. severe hepatic insufficiency 7. fluvoxamine use	1. mild covid-19 disease (minor clinical symptoms, imaging does not show signs of lung inflammation) 2. recent history of or any in-hospital exposure to investigational medications targeting covid-19 3. alt/ast > 5 times the upper limit of normal. 4. known hypersensitivity to ramelteon 5. pregnancy 6. severe hepatic insufficiency 7. fluvoxamine use